?????????
Conditions
Interventions
Case series:Rabbit Anti-thymocyte Immunoglobulin (Thymoglobuline) Induction Therapy
Sponsors
The First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Chinese patients who were recipients of a cardiac death renal allograft from 01-Jan-2012 to 30-Apr-2015 (including donation after brain death followed by cardiac death); 2) Aged 18 years or older; 3) Patients have received kidney transplant with Thymoglobuline? induction therapy.
Exclusion criteria
Exclusion criteria: 1) Patients with multiple organ transplants; 2) Patients with previous kidney or other organ transplant history.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of acute rejection (AR) at Month 12 in recipents from DCD kidney transplant using Thymoglobuline induction therapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of AR at Month 6;The incidence of Delayed graft function (DGF) at Month 12;Duration of DGF at Month 12;Graft survival and patient survival at Month12;Possible risk factors related to the incidence of AR and DGF;Comparison incidence of AR between standard dose (=4.5 mg/kg) and low dose (<4.5 mg/kg) of Thymoglobuline? in subgroups by adjusting covariates; | — |
Countries
China
Contacts
Public ContactJuan Yao
SANOFI (CHINA) INVESTMENT CO., LTD. SHANGHAI BRANCH
Outcome results
None listed